MHB2 Medical Costs of Venlafaxine Versus Tricyclic or Tetracyclic Antidepressant Therapy After Switching from Selective Serotonin Reuptake Inhibitors
Abstract
Authors
RI Griffiths EM Sullivan RG Frank RJ Herbert MJ Strauss HH Goldman